This educational program will explore the latest developments in ICI-based therapies, providing comprehensive insights into their efficacy and safety profiles. By analyzing real-world clinical cases, participants will learn how to incorporate emerging clinical evidence into personalized treatment plans, addressing both BRAF-mutant and wild-type melanoma. Additionally, the program will cover the management of immune-related adverse events a crucial consideration when using ICI-based therapies. Ultimately, this activity aims to enhance clinicians understanding and empower them to make informed decisions, thereby advancing the care for those with advanced melanoma.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/oncologyce/melanoma/20241104/advanced-melanoma-optimizing-ici-based-therapies/overview
- Start Date: 2024-11-22 06:00:00
- End Date: 2024-11-22 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Bristol Myers Squibb - Amount: 22500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest